▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Pointing to upward chart

Apr 21, 2019 by Keith Speights

3 Healthcare Stocks Hitting 52-Week Highs: Are They Buys?

Can the sizzling momentum continue for these high-flying healthcare stocks?

Marijuana growing in greenhouse

Apr 20, 2019 by Keith Speights

Better Marijuana Stock: Cronos Group vs. MariMed

A high-flying Canadian marijuana stock in one corner. A high-flying U.S. marijuana stock in the other. Which emerges as the winner?

Big fish little fish

Apr 20, 2019 by Keith Speights

Would Pfizer Shareholders Win With an Acquisition of Amarin?

A Pfizer buyout of Amarin is still just a rumor. But rumors sometimes turn into reality.

Retired couple walking down dirt road

Apr 20, 2019 by Keith Speights

If You're Retired, Consider Buying These 3 Stocks

Three stocks in three industries with one common denominator.

Hands holding $100 bills and a cannabis leaf

Apr 20, 2019 by Keith Speights

Tilray Dodges a Bullet -- Is the Hot Marijuana Stock Now a Buy?

Tilray's IPO lockup period expiration could have been a lot worse. Is now the time to scoop up shares?

Stacks of coins with pill bottle

Apr 20, 2019 by Keith Speights

Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?

The answer: It's complicated.

Businessmen shaking hands

Apr 20, 2019 by Keith Speights

Recent Deals for Canopy Growth and Aurora Cannabis Show Why One of These Marijuana Stocks Is a Great Pick -- and One Isn't

Two deals for two big Canadian marijuana producers were announced on the same day, and they hint as to why one of these marijuana stocks is the clear winner.

DNA on top of hand

Apr 20, 2019 by Keith Speights

Could CRISPR Therapeutics Be a Millionaire-Maker Stock?

This gene-editing biotech should have a huge growth opportunity in front of it. But is it enough to make you a millionaire?

Plastic bottle with cannabis spilling out next to cash

Apr 20, 2019 by Keith Speights

Better Marijuana Stock: Hexo vs. KushCo Holdings

Which stock wins in a matchup between this Canadian marijuana producer and the top packaging supplier to the U.S. cannabis industry?

Flask and lab background

Apr 20, 2019 by Keith Speights

Better Buy: Biogen vs. Gilead Sciences

Which stock wins in a battle between these two big biotechs?

Marijuana leaves with shadow of dollar sign

Apr 18, 2019 by Keith Speights

Why Tilray Is Sinking Today

Insiders were able to sell their shares for the first time on Tuesday. And their selling took a toll on Tilray's share price.

Worried man looking at computer

Apr 18, 2019 by Keith Speights

5 Worrisome Words in Aurora Cannabis' Q2 Guidance

Growth but no growth? That's what Aurora Cannabis expects in one area critical for its future.

Marijuana leaves surrounding red Canadian maple leaf

Apr 17, 2019 by Keith Speights

Better Buy: OrganiGram Holdings vs. CannTrust Holdings

These are two exceptional Canadian marijuana stocks, but one of them gives investors a little more oomph.

Marijuana leaf next to 3D bar chart

Apr 17, 2019 by Keith Speights

These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year

Repeat performances could be in store for these big marijuana winners from last year.

Marijuana close-up in greenhouse

Apr 17, 2019 by Keith Speights

Better Buy: Aurora Cannabis vs. Scotts Miracle-Gro

Which stock wins in a matchup between a top Canadian marijuana producer and a big lawn and gardens supplier with a growing cannabis business?

$10 bills

Apr 17, 2019 by Keith Speights

3 Great Stocks Under $10

It's not the low share price that makes these stocks attractive, it's their huge growth prospects.

Baseball on top of money

Apr 17, 2019 by Keith Speights

Intuitive Surgical Is Playing Moneyball -- and Investors Will Be the Winners

The robotic surgical system's greatest strength might be its data-driven approach.

Dividends tab on $100 bill

Apr 17, 2019 by Keith Speights

3 Top Dividend Stocks Selling at a Discount Right Now

Great yields. Great bargains. What more could you ask for?

Beaker with money in it

Apr 17, 2019 by Keith Speights, Sean Williams, and Brian Feroldi

3 Top Biotech Stocks to Buy in January

Adding these biotech stocks to your portfolio could be a great New Year's resolution for aggressive investors.

Soaring man and chart

Apr 17, 2019 by Keith Speights

3 Biotech Stocks That Soared This Week: Are They Buys?

These biotech stocks jumped 31% or more over the last few days. Can their momentum continue?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services